Small molecules combined with collagen hydrogel direct neurogenesis and migration of neural stem cells after spinal cord injury

Yaming Yang,Yongheng Fan,Haipeng Zhang,Qi Zhang,Yannan Zhao,Zhifeng Xiao,Wenbin Liu,Bing Chen,Lin Gao,Zheng Sun,Xiaoyu Xue,Muya Shu,Jianwu Dai

DOI: https://doi.org/10.1016/j.biomaterials.2020.120479

IF: 14

2021-02-01

Biomaterials

Abstract:<p>Complete spinal cord injury (SCI) leads to cell death, interruption of axonal connections and permanent functional impairments. In the development of SCI treatments, cell transplantation combined with biomaterial-growth factor-based therapies have been widely studied. Another avenue worth exploring is the generation of neurons from endogenous neural stem cells (NSCs) or reactive astrocytes activated by SCI. Here, we screened a combination of four small molecules, LDN193189, SB431542, CHIR99021 and P7C3-A20, that can increase neuronal differentiation of mouse and rat spinal cord NSCs. Moreover, the small molecules loaded in an injectable collagen hydrogel induced neurogenesis and inhibited astrogliogenesis of endogenous NSCs in the injury site, which usually differentiate into astrocytes under pathological conditions. Meanwhile, induced neurons migrated into the non-neural lesion core, and genetic fate mapping showed that neurons mainly originated from NSCs in the parenchyma, but not from the central canal of the spinal cord. The neuronal regeneration in the lesion sites resulted in some recovery of locomotion. Our findings indicate that small molecules combined and collagen hydrogel is a potential therapeutic strategy for SCI by inducing endogenous <em>in situ</em> NSCs to form neurons and restore damaged functions.</p>

engineering, biomedical,materials science, biomaterials

What problem does this paper attempt to address?

This paper aims to address the issue of neural function recovery after complete spinal cord injury (SCI). Specifically, the authors screened four small molecules (LDN193189, SB431542, CHIR99021, and P7C3-A20) that can promote the differentiation of spinal cord neural stem cells (NSCs) into neurons in mice and rats. Additionally, by combining these small molecules with injectable collagen hydrogel, they induced the generation of neurons from endogenous neural stem cells at the injury site and inhibited their differentiation into astrocytes. Experimental results showed that the induced neurons could migrate to the non-neuronal injury core area, and genetic lineage tracing revealed that these neurons mainly originated from neural stem cells in the spinal cord parenchyma rather than cells in the central canal. This strategy promoted motor function recovery to a certain extent. The study also explored the specific mechanisms of action of different small molecules and validated the effectiveness of this method in a rat model.